Specialist Profile

Comprehensive Clinical Care in Bone Marrow Transplant & Advanced Cellular Immunotherapy in Faridabad and Gurugram

Dr. Amrita Chakrabarti - Bone Marrow Transplant Specialist in Faridabad and Gurugram

Dr. Amrita Chakrabarti

Consultant — Hemato-Oncology & Bone Marrow Transplant
🎓 FRCPath Haematology (London, UK) DipRCPath (London) DNB MBBS
12+ Years Clinical Practice
UK & India Tertiary Centers
FRCPath London Certified
CAR-T Cell Therapy Specialist

Dr. Amrita Chakrabarti

Consultant — Hemato-Oncology & Bone Marrow Transplant
🎓 FRCPath Haematology (London, UK) DipRCPath (London) DNB MBBS

Recognized as a leading hematologist in Faridabad and Gurugram and dedicated bone marrow transplant specialist in Faridabad and Gurugram, Dr. Amrita Chakrabarti brings over 12 years of clinical excellence in hemato-oncology, cellular therapy, and benign blood disorders across high-volume tertiary hospitals in Delhi NCR and NHS England. With specialized clinical affiliations in CAR-T cell immunotherapy and hematopoietic stem cell transplantation from Queen Elizabeth Hospitals (Birmingham, UK), she delivers evidence-based, protocol-driven clinical care (NICE and BSH guidelines) across all hematological complexities.

Autologous, Allogeneic & Haploidentical SCT
UK-Trained CAR-T Cell Immunotherapy
Comprehensive Platelet & Bleeding Disorders
Lead BMT Specialist in Faridabad & Gurugram

Comprehensive Hematology & Clinical Spectrum

Complete protocol-driven diagnosis and treatment pathways across benign, malignant, platelet, and cellular hematology.

🩸

Platelet & Bleeding Disorders

Dedicated diagnostic workup and acute/chronic management of low platelet counts, autoimmune platelet destruction, and qualitative platelet dysfunctions.

Immune Thrombocytopenia (ITP - Adult & Child) Thrombotic Thrombocytopenic Purpura (TTP) Hemolytic Uremic Syndrome (HUS / aHUS) Gestational Thrombocytopenia Heparin-Induced Thrombocytopenia (HIT) Glanzmann Thrombasthenia Bernard-Soulier Syndrome Drug-Induced Thrombocytopenia (DITP) Neonatal Alloimmune Thrombocytopenia (NAIT) Platelet Storage Pool Deficiencies
🛡️

Thrombosis & Coagulation

Comprehensive thrombophilia evaluation, genetic clotting risk mapping, anticoagulation stewardship, and congenital factor deficiency management.

Deep Vein Thrombosis (DVT) Pulmonary Embolism (PE) Antiphospholipid Syndrome (APLA) Factor V Leiden Mutation Prothrombin Gene Mutation Protein C & Protein S Deficiency Antithrombin III Deficiency Hemophilia A (Factor VIII) & B (Factor IX) Von Willebrand Disease (Type 1, 2, 3) Rare Coagulation Factor Deficiencies
🧬

Stem Cell Transplants (BMT)

Precision conditioning regimens, stem cell mobilization, cryopreservation, and inpatient transplant management for malignant and genetic failures.

Autologous Stem Cell Transplant Allogeneic Matched Sibling Donor (MSD) Haploidentical (Half-Matched Family BMT) Matched Unrelated Donor (MUD) Transplants Umbilical Cord Blood Transplants Post-Transplant GVHD Prophylaxis & Care Total Marrow Irradiation (TMI) Protocols
🔬

CAR-T & Cellular Therapy

Next-generation living cell infusions trained at Queen Elizabeth Hospitals Birmingham, with 24x7 ICU neurotoxicity monitoring.

Relapsed/Refractory B-Cell ALL Diffuse Large B-Cell Lymphoma (DLBCL) High-Grade B-Cell Non-Hodgkin Lymphoma Cytokine Release Syndrome (CRS) Protocol ICANS Neurotoxicity Management Cellular Apheresis & T-Cell Harvesting Targeted Monoclonal Antibodies
⚕️

Leukemia Spectrum

Multi-agent induction chemotherapy, targeted biologics, and molecular response tracking (MRD) for myeloid and lymphoid blood cancers.

Acute Myeloid Leukemia (AML) Acute Lymphoblastic Leukemia (ALL) Acute Promyelocytic Leukemia (APML) Chronic Myeloid Leukemia (CML) Chronic Lymphocytic Leukemia (CLL) T-Cell Prolymphocytic Leukemia (T-PLL) Hairy Cell Leukemia (HCL) Mixed Phenotype Acute Leukemia (MPAL)
🎗️

Lymphomas & Myeloma

Staging, immunochemotherapy, and transplant pathways for nodal diseases and monoclonal immunoglobulin plasma disorders.

Multiple Myeloma (Smoldering & Active) Hodgkin Lymphoma (Classical & NLPHL) Non-Hodgkin Lymphoma (Follicular, Mantle) Burkitt Lymphoma & Marginal Zone Primary CNS Lymphoma AL Amyloidosis & ALECT-2 Amyloidosis Waldenström Macroglobulinemia Plasmacytoma & POEMS Syndrome
⚠️

Marrow Failures & MPN

Investigative marrow biopsies, cytogenetics, immunosuppressive therapies, and hypomethylating strategies for cellular depletion.

Severe Aplastic Anemia Myelodysplastic Syndromes (MDS) Primary Myelofibrosis (PMF) Polycythemia Vera (PV) Essential Thrombocythemia (ET) Chronic Myelomonocytic Leukemia (CMML) Paroxysmal Nocturnal Hemoglobinuria (PNH) Pure Red Cell Aplasia (PRCA) Hemophagocytic Lymphohistiocytosis (HLH)
🧪

Hemoglobinopathies & Anemias

Definitive genetic screening, transfusion-iron chelation protocols, and allogeneic curative transplant counseling.

Thalassemia Major & Thalassemia Intermedia Sickle Cell Anemia & Vaso-occlusive Crisis HbE / Beta-Thalassemia Syndromes Autoimmune Hemolytic Anemia (Warm & Cold AIHA) G6PD Deficiency & Enzymopathies Hereditary Spherocytosis & Elliptocytosis Refractory Iron Deficiency Anemia Megaloblastic Anemia & Vitamin B12 Defects Anemia of Chronic Kidney Disease / Cancer

🏥 Clinical Career & Tertiary Experience

  • Sandwell & West Birmingham Hospitals NHS Trust (UK)
    Served as Consultant Haematologist delivering evidence-based clinical hematology care within structured British clinical governance frameworks.
  • Queen Elizabeth Hospitals, Birmingham (UK)
    Clinical affiliation in advanced cellular therapy, CAR-T cell infusion protocols, and complex allogeneic stem cell transplant pathways.
  • Premier Oncology Institutes (India)
    Over 12 years of clinical practice as senior consultant hematologist across institutions including Medanta – The Medicity (Gurugram), Max Healthcare, Fortis Healthcare, and Apollo Gleneagles Hospitals.
  • Integrated Diagnostic & Morphological Precision
    Expertise in reporting peripheral blood smears, bone marrow aspiration and trephine biopsies, lymph node histopathology, Flow Cytometry, and Immunohistochemistry (IHC).

🎓 Academic Qualifications & Training

  • FRCPath Haematology (London, UK)
    Fellow of the Royal College of Pathologists, United Kingdom.
  • DipRCPath Haematology (London, UK)
    Diploma of the Royal College of Pathologists, United Kingdom.
  • Clinical Affiliation in CAR-T & Stem Cell Transplant
    Queen Elizabeth Hospitals, University Hospitals Birmingham NHS Foundation Trust, UK.
  • Diplomate of National Board (DNB) & MBBS
    National Board Examination (DNB Pathology) and Bachelor of Medicine, Bachelor of Surgery (MBBS).

🏆 Clinical Honors & Research Contributions

🎖️
Times of India Leaders in Healthcare Award (2025) Conferred for Leadership and Clinical Excellence in Haematology
🏅
Excellence Award — Amim Cancer Trust Recognized as Best Hemato-Oncologist, Delhi NCR
  • International Clinical Memberships: Active Fellow of the Royal College of Pathologists (UK), regularly invited as faculty, speaker, and panelist across national and international hematology congresses.
  • 25+ Peer-Reviewed Research Publications: Primary author and investigator across journals including Transplant and Cellular Therapy, Biology of Blood and Marrow Transplantation (BBMT), Blood Cells, Molecules and Diseases, and Magazine of European Medical Oncology.
  • Pioneering Stem Cell Research: Co-authored key trials on Bendamustine (BACE) conditioning for autologous lymphoma transplants, post-transplant GVHD prophylaxis in haploidentical SCT, and Total Marrow Irradiation (TMI) conditioning.

Take The Next Step With Our Clinical Team

For advanced second opinions, donor evaluations, conditioning protocols, and evidence-based hematology care, consult Dr. Amrita Chakrabarti, leading hematologist and bone marrow transplant specialist in Faridabad and Gurugram at BMT Next, Marengo Asia Hospitals.